FDA NDC Directory · JSON-LD · Markdown

IRESSA

NDC 0310-0482 · HUMAN PRESCRIPTION DRUG · TABLET, COATED

Generic nameGefitinib
Labeler / ManufacturerAstraZeneca Pharmaceuticals LP
Marketing categoryNew Drug Application (innovator) · App NDA206995
Dosage form / routeTABLET, COATED · ORAL
Active ingredientsGEFITINIB (250 mg/1)
Marketing started20150713
Package count1

External sources

Source: openFDA. Public-domain (CC0).